Nerve growth factor as a paradigm of neurotrophins related to Alzheimer's disease

Developmental Neurobiology

Volumn 70, Issue 5, 2010, Pages 372-383

  Calissano, P ^a,b   Matrone, C ^a   Amadoro, G ^a  

^a Institute of Neurobiology and Molecular Medicine   (Italy)

^b EUROPEAN BRAIN RESEARCH INSTITUTE   (Italy)

Author keywords

Beta amyloid; NGF; Tau

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN ANTIBODY; BETA SECRETASE; BETA SECRETASE INHIBITOR; BRAIN DERIVED NEUROTROPHIC FACTOR; GAMMA SECRETASE INHIBITOR; NERVE GROWTH FACTOR; NEUROTROPHIN; PROTEIN P75; PROTEIN PS1; PROTEIN TYROSINE KINASE A; TAU PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; CELL AGGREGATION; CYTOSKELETON; HUMAN; IN VITRO STUDY; MICROTUBULE; NERVE CELL PLASTICITY; NERVE FIBER TRANSPORT; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION;

ALZHEIMER DISEASE; ANIMALS; HUMANS; MODELS, NEUROLOGICAL; NERVE GROWTH FACTOR; NERVE GROWTH FACTORS;

EID: 77949660874     PISSN: 19328451     EISSN: 10974695     Source Type: Journal    
DOI: 10.1002/dneu.20759     Document Type: Review

References (146)

1. Akaneya Y, Tsumoto T, Kinoshita S, Hatanaka H. 1997. Brain-derived neurotrophic factor enhances long-term potentiation in rat visual cortex. J Neurosci 17:6707-6716.
2. Alonso AD, Grundke-Iqbal I, Barra HS, Iqbal K. 1997. Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: Sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau. Proc Natl Acad Sci USA 94:298-303.
3. Amadoro G, Corsetti V, Ciotti MT, Florenzano F, Capsoni S, Amato G, Calissano P. 2009. Endogenous Aβ causes cell death via early tau hyperphosphorylation. Neurobiol Aging. DOI: 10.1016/j.neurobiolaging.2009.06. 005.
4. Araki W, Wurtman RJ. 1998. Increased expression of amyloid precursor protein and amyloid precursor-like protein 2 during trophic factor withdrawal-induced death of neuronal PC12 cells. Brain Res Mol Brain Res 56(1-2):169-177.
5. Babu JR, Geetha T, Wooten MW. 2005. Sequestosome 1/p62 shuttles polyubiquitinated tau for proteasomal degradation. J Neurochem 94:192-203.
6. Barnabe-Heider F, Miller FD. 2003. Endogenously produced neurotrophins regulate survival and differentiation of cortical progenitors via distinct signaling pathways. J Neurosci 23:5149-5160.
7. Berardi N, Cellerino A, Domenici L, Fagiolini M, Pizzorusso T, Cattaneo A, Maffei L. 1994. Monoclonal antibodies to nerve growth factor affect the postnatal development of the visual system. Proc Natl Acad Sci USA 91:684-688.
8. Blurton-Jones M, Kitazawa M, Martinez-Coria H, Castello NA, Müller FJ, Loring JF, Yamasaki TR, et al. 2009. Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proc Natl Acad Sci USA 106:13594-13599.
9. Boissière F, Hunot S, Faucheux B, Hersh LB, Agid Y, Hirsch EC. 1997. Trk neurotrophin receptors in cholinergic neurons of patients with Alzheimer's disease. Dement Geriatr Cogn Disord 8:1-8.
10. Bonhoeffer T. 1996. Neurotrophins and activity-dependent development of the neocortex. Curr Opin Neurobiol 6:119-126.
11. Boulanger L, Poo M. 1999. Gating of BDNF-induced synaptic potentiation by cAMP. Science 284:1982-1984.
12. Brancucci A, Kuczewski N, Covaceuszach S, Cattaneo A, Domenici L. 2004. Nerve growth factor favours long-term depression over long-term potentiation in layer II-III neurones of rat visual cortex. J Physiol 559(Part 2):497-506.
13. Bruno MA, Cuello AC. 2006. Activity-dependent release of precursor nerve growth factor, conversion to mature nerve growth factor, and its degradation by a protease cascade. Proc Natl Acad Sci USA 103:6735-6740.
14. Bulbarelli A, Lonati E, Cazzaniga E, Re F, Sesana S, Barisani D, Sancini G, et al. 2009. TrkA pathway activation induced by amyloid-beta (Ab). Mol Cell Neurosci 40:365-373.
15. Capsoni S, Cattaneo A. 2006. On the molecular basis linking nerve growth factor (NGF) to Alzheimer's disease. Cell Mol Neurobiol 26:619-633.
16. Capsoni S, Giannotta S, Cattaneo A. 2002a. Early events of Alzheimer-like neurodegeneration in anti-nerve growth factor transgenic mice. Brain Aging 2:24-43.
17. Capsoni S, Giannotta S, Cattaneo A. 2002b. Nerve growth factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice. Proc Natl Acad Sci USA 17;99:12432-12437.
18. Capsoni S, Ugolini G, Comparini A, Ruberti F, Berardi N, Cattaneo A. 2000. Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice. Proc Natl Acad Sci USA 97:6826-6831.
19. Cattaneo A, Capsoni S, Paoletti F. 2008. Towards non invasive nerve growth factor therapies for Alzheimer's disease. J Alzheimers Dis 15:255-283. Review.
20. Chao M. 2003. Neurotrophins and their receptors: A convergence point for many signaling pathways. Nat Rev Neurosci 4:299-309.
21. Chao MV, Rajagopal R, Lee FS. 2006. Neurotrophin signaling in health and disease. Clin Sci (Lond) 110:167-173. Review.
22. Chu Y, Cochran EJ, Bennett DA, Mufson EJ, Kordower JH. 2001. Down-regulation of trkA mRNA within nucleus basalis neurons in individuals with mild cognitive impairment and Alzheimer's disease. J Comp Neurol 27; 437:296-307.
23. Coleman PD, Yao PJ. 2003. Synaptic slaughter in Alzheimer's disease. Neurobiol Aging 24:1023-1027. Review.
24. Conner J, Franks K, Titterness A, Russell K, Merrill D, Christie B, Sejnowski T, et al. 2009. NGF is essential for hippocampla plasticity and learning. J Neurosci 29:10883-10889.
25. Cooper JD, Lindholm D, Sofroniew MV. 1994. Reduced transport of [125I]nerve growth factor by cholinergic neurons and down-regulated TrkA expression in the medial septum of aged rats. Neuroscience 62:625-629.
26. Cooper JD, Salehi A, Delcroix JD, Howe CL, Belichenko PV, Chua-Couzens J, Kilbridge JF, et al. 2001. Failed retrograde transport of NGF in a mouse model of Down's syndrome: reversal of cholinergic neurodegenerative phenotypes following NGF infusion. Proc Natl Acad Sci USA 28;98:10439-10444.
27. Corsetti V, Amadoro G, Gentile A, Capsoni S, Ciotti MT, Cencioni MT, Atlante A, et al. 2008. Identification of a caspase-derived N-terminal tau fragment in cellular and animal Alzheimer's disease models. Mol Cell Neurosci 38:381-392.
28. Cosgaya JM, Latasa MJ, Pascual A. 1996. Nerve growth factor and ras regulate b-amyloid precursor protein gene expression in PC12 cells. J Neurochem 67:98-104.
29. Costantini C, Della-Bianca V, Formaggio E, Chiamulera C, Montresor A, Rossi F. 2005b. The expression of p75 neurotrophin receptor protects against the neurotoxicity of soluble oligomers of β-amyloid. Exp Cell Res 311:126-134.
30. Costantini C, Rossi F, Formaggio E, Bernardoni R, Cecconi D, Della-Bianca V. 2005c. Characterization of the signaling pathway downstream p75 neurotrophin receptor involved in β-amyloid peptide-dependent cell death. J Mol Neurosci 25:141-156.
31. Costantini C, Scrable H, Puglielli L. 2006. An aging pathway controls the TrkA to p75NTR receptor switch and amyloid β-peptide generation. EMBO J 25:1997-2006.
32. Costantini C, Weindruch R, Della Valle G, Puglielli LA. 2005a. TrkA-to-p75NTR molecular switch activates amyloid β-peptide generation during aging. Biochem J 391(Part 1):59-67.
33. Coulson EJ. 2006. Does the p75 neurotrophin receptor mediate Aβ-induced toxicity in Alzheimer's disease? J Neurochem 98:654-660.
34. Counts SE, Nadeem M, Wuu J, Ginsberg SD, Saragovi HU, Mufson EJ. 2004. Reduction of cortical TrkA but not p75(NTR) protein in early-stage Alzheimer's disease. Ann Neurol 56:520-531.
35. Crutcher KA, Scott SA, Liang S, Everson WV, Weingartner J. 1993. Detection of NGF-like activity in human brain tissue: Increased levels in Alzheimer's disease. J Neurosci 13:2540-2550.
36. Cuello AC, Bruno MA. 2007. The failure in NGF maturation and its increased degradation as the probable cause for the vulnerability of cholinergic neurons in Alzheimer's disease. Neurochem Res 32:1041-1045; Epub 2007 Apr 3 Review Erratum in Neurochem Res 32:1718.
37. Culmsee C, Gerling N, Lehmann M, Nikolova-Karakashian M, Prehn JH, Mattson MP, Krieglstein J. 2002. Nerve growth factor survival signaling in cultured hippocampal neurons is mediated through TrkA and requires the common neurotrophin receptor p75. Neuroscience 115:1089-1108.
38. De Rosa R, Garcia AA, Braschi C, Capsoni S, Maffei L, Berardi N, Cattaneo A. 2005. Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice. Proc Natl Acad Sci USA 102:3811-3816.
39. Delcroix JD, Valletta J, Wu C, Howe CL, Lai CF, Cooper JD, Belichenko PV, et al. 2004. Trafficking the NGF signal: Implications for normal and degenerating neurons. Prog Brain Res 146:3-23.
40. Dixit R, Ross JL, Goldman YE, Holzbaur EL. 2008. Differential regulation of dynein and kinesin motor proteins by tau. Science 319:1086-1089.
41. Domenici L, Cellerino A, Berardi N, Cattaneo A, Maffei L. 1994. Antibodies to nerve growth factor (NGF) prolong the sensitive period for monocular deprivation in the rat. Neuroreport 5:2041-2044.
42. Drubin DG, Feinstein SC, Shooter EM, Kirschner MW. 1985. Nerve growth factor-induced neurite outgrowth in PC12 cells involves the coordinate induction of microtubule assembly and assembly-promoting factors. J Cell Biol 101(Part 1):1799-1807.
43. Ebneth A, Godemann R, Stamer K, Illenberger S, Trinczek B, Mandelkow E. 1998. Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: Implications for Alzheimer's disease. J Cell Biol 143:777-794.
44. Ernfors P, Bramham CR. 2003. The coupling of a trkB tyrosine residue to LTP. Trends Neurosci 26:171-173.
45. Fahnestock M, Michalski B, Xu B, Coughlin MD. 2001. The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease. Mol Cell Neurosci 18:210-220.
46. Fahnestock M, Scott SA, Jetté N, Weingartner JA, Crutcher KA. 1996. Nerve growth factor mRNA and protein levels measured in the same tissue from normal and Alzheimer's disease parietal cortex. Brain Res Mol Brain Res 42:175-178.
47. Figurov A, Pozzo-Miller LD, Olafsson P, Wang T, Lu B. 1996. Regulation of synaptic responses to high-frequency stimulation and LTP by neurotrophins in the hippocampus. Nature 381:706-709.
48. Gauthier LR, Charrin BC, Borrell-Pagès M, Dompierre JP, Rangone H, Cordelières FP, De Mey J, et al. 2004. Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 118:127-138.
49. Ge YW, Lahiri DK. 2002. Regulation of promoter activity of the APP gene by cytokines and growth factors: Implications in Alzheimer's disease. Ann NY Acad Sci 973:463-467.
50. Ginsberg SD, Che S, Wuu J, Counts SE, Mufson EJ. 2006. Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease. J Neurochem 97:475-487.
51. Goedert M, Fine A, Hunt SP, Ullrich A. 1986. Nerve growth factor mRNA in peripheral and central rat tissues and in the human central nervous system: Lesion effects in the rat brain and levels in Alzheimer's disease. Brain Res 387:85-92.
52. Grumolato L, Louiset E, Alexandre D, Ait-Ali D, Turquier V, Fournier A, Fasolo A, et al. 2003. PACAP and NGF regulate common and distinct traits of the sympathoadrenal lineage: Effects on electrical properties, gene markers and transcription factors in differentiating PC12 cells. Eur J Neurosci 17:71-82.
53. Hamburger V. 1934. The effects of wing bug extirpation in chick embryos on the development of the central nervous system. J Exp Zool 68:449-494.
54. Hartmann M, Heumann R, Lessmann V. 2001. Synaptic secretion of BDNF after high-frequency stimulation of glutamatergic synapses. EMBO J 20:5887-5897.
55. Hattiangady B, Rao MS, Shetty GA, Shetty AK. 2005. Brain-derived neurotrophic factor, phosphorylated cyclic AMP response element binding protein and neuropeptide Y decline as early as middle age in the dentate gyrus and CA1 and CA3 subfields of the hippocampus. Exp Neurol 195:353-371.
56. Hefti F, Weiner WJ. 1986. Nerve growth factor and Alzheimer's disease. Ann Neurol 20:275-281.
57. Hellweg R, Gericke CA, Jendroska K, Hartung HD, Cervós-Navarro J. 1998. NGF content in the cerebral cortex of non-demented patients with amyloid-plaques and in symptomatic Alzheimer's disease. Int J Dev Neurosci 16(7-8):787-794.
58. Hock C, Heese K, Hulette C, Rosenberg C, Otten U. 2000. Region-specific neurotrophin imbalances in Alzheimer disease: Decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas. Arch Neurol 57:846-851.
59. Hock C, Heese K, Müller-Spahn F, Hulette C, Rosenberg C, Otten U. 1998. Decreased trkA neurotrophin receptor expression in the parietal cortex of patients with Alzheimer's disease. Neurosci Lett 241(2-3):151-154.
60. Howe CL, Mobley WC. 2005. Long-distance retrograde neurotrophic signaling. Curr Opin Neurobiol 15:40-48.
61. Hu XY, Zhang HY, Qin S, Xu H, Swaab DF, Zhou JN. 2002. Increased p75(NTR) expression in hippocampal neurons containing hyperphosphorylated tau in Alzheimer patients. Exp Neurol 178:104-111.
62. Jacobsen SJ, Wu CC, Redwine JM, Comery TA, Arias R, Bowlby M, Martone R, et al. 2006 Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 103:5161-5166.
63. Jetté N, Cole MS, Fahnestock M. 1994. NGF mRNA is not decreased in frontal cortex from Alzheimer's disease patients. Brain Res Mol Brain Res 25(3-4):242-250.
64. Kang H, Schuman EM. 1995. Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus. Science 267:1658-1662.
65. Kerwin JM, Morris CM, Perry RH, Perry EK. 1992. Hippocampal nerve growth factor receptor immunoreactivity in patients with Alzheimer's and Parkinson's disease. Neurosci Lett 31;143(1-2):101-104.
66. Kojima M, Takei N, Numakawa T, Ishikawa Y, Suzuki S, Matsumoto T, Katoh-Semba R, et al. 2001. Biological characterization and optical imaging of brain-derived neurotrophic factor86 green fluorescent protein suggest an activity-dependent local release of brain-derived neurotrophic factor in neurites of cultured hippocampal neurons. J Neurosci Res 64:1-10.
67. Kuhn HG, Dickinson-Anson H, Gage FH. 1996. Neurogenesis in the dentate gyrus of the adult rat: Age-related decrease of neuronal progenitor proliferation. J Neurosci 16:2027-2033.
68. Lahiri DK, Nall C. 1995. Promoter activity of the gene encoding the b-amyloid precursor protein is up-regulated by growth factors, phorbol ester, retinoic acid and interleukin-1. Brain Res Mol Brain Res 32:233-240.
69. Lazarov O, Morfini GA, Pigino G, Gadadhar A, Chen X, Robinson J, Ho H, et al. 2007. Impairments in fast axonal transport and motor neuron deficits in transgenic mice expressing familial Alzheimer's disease-linked mutant presenilin 1. J Neurosci 27:7011-7020.
70. Lee J, Duan W, Mattson MP. 2002. Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice. J Neurochem 82:1367-1375.
71. Lesser SS, Holmes TM, Pittman AJ, Lo DC. 1999. Induction of electrical excitability by NGF requires autocrine action of a CNTF-like factor. Mol Cell Neurosci 14:169-179.
72. Lessmann V. 1998. Neurotrophin-dependent modulation of glutamatergic synaptic transmission in the mammalian CNS. Gen Pharmacol 31:667-674. Review.
73. Levi Montalcini R. 1987. The nerve growth factor 35 years later. Science 237:1154-1162.
74. Levi Montalcini R, Levi G. 1942. Les consequences de la destruction d'un territoire pèripherique sur le development des centre nervaux correspondans dans l'embryon du poulet. Arch Biol LIII:537, 545.
75. Levine ES, Dreyfus CF, Black IB, Plummer MR. 1995. Differential effects of NGF and BDNF on voltage-gated calcium currents in embryonic basal forebrain neurons. J Neurosci 15:3084-3091.
76. Lodovichi C, Berardi N, Pizzorusso T, Maffei L. 2000. Effects of neurotrophins on cortical plasticity: Same or different? J Neurosci 20:2155-2165.
77. Longo FM, Yang T, Knowles JK, Xie Y, Moore LA, Massa SM. 2007. Small molecule neurotrophin receptor ligands: Novel strategies for targeting Alzheimer's disease mechanisms. Curr Alzheimer Res 4:503-506.
78. Lu B, Pang PT, Woo NH. 2005. The yin and yang of neurotrophin action. Nat Rev Neurosci 6:603-614. Review.
79. Maffei L, Berardi N, Domenici L, Parisi V, Pizzorusso T. 1992. Nerve growth factor (NGF) prevents the shift in ocular dominance distribution of visual cortical neurons in monocularly deprived rats. J Neurosci 12:4651-4662.
80. Magnani E, Fan J, Gasparini L, Golding M, Williams M, Schiavo G, Goedert M, et al. 2007. Interaction of tau protein with the dynactin complex. EMBO J 31;26:4546-4554.
81. Mandelkow EM, Stamer K, Vogel R, Thies E, Mandelkow E. 2003. Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses. Neurobiol Aging 24:1079-1085.
82. Matrone C, Ciotti MT, Mercanti D, Marolda R, Calissano P. 2008b. NGF and BDNF signaling control amyloidogenic route and Ab production in hippocampal neurons. Proc Natl Acad Sci USA 105:13139-13144.
83. Matrone C, Di Luzio A, Meli G, D'Aguanno S, Severini C, Ciotti MT, Cattaneo A, et al. 2008a. Activation of the amyloidogenic route by NGF deprivation induces apoptotic death in PC12 cells. J Alzheimers Dis 3:81-96.
84. Matrone C, Marolda R, Ciafrè S, Ciotti MT, Mercanti D, Calissano P. 2009. Tyrosine kinase nerve growth factor receptor switches from prosurvival to proapoptotic activity via Aβ-mediated phosphorylation. Proc Natl Acad Sci USA 106:11358-11363.
85. Mobley WC, Neve RL, Prusiner SB, McKinley MP. 1998. Nerve growth factor increases mRNA levels for the prion protein and the β-amyloid protein precursor in developing hamster brain. Proc Natl Acad Sci USA 85:9811-9815.
86. Mufson EJ, Conner JM, Kordower JH. 1995. Nerve growth factor in Alzheimer's disease: Defective retrograde transport to nucleus basalis. Neuroreport 6:1063-1036.
87. Mufson EJ, Ginsberg SD, Ikonomovic MD, DeKosky ST. 2003. Human cholinergic basal forebrain: Chemoanatomy and neurologic dysfunction. J Chem Neuroanat 26:233-242. Review.
88. Mufson EJ, Lavine N, Jaffar S, Kordower JH, Quirion R, Saragovi HU. 1997. Reduction in p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease. Exp Neurol 146:91-103.
89. Mufson EJ, Li JM, Sobreviela T, Kordower JH. 1996. Decreased trkA gene expression within basal forebrain neurons in Alzheimer's disease. Neuroreport 8:25-29.
90. Mufson EJ, Ma SY, Cochran EJ, Bennett DA, Beckett LA, Jaffar S, Saragovi HU, et al. 2000. Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease. J Comp Neurol 427:19-30.
91. Mufson EJ, Ma SY, Dills J, Cochran EJ, Leurgans S, Wuu J, Bennett DA, et al. 2002. Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease. J Comp Neurol 443:136-153.
92. Narisawa-Saito M, Wakabayashi K, Tsuji S, Takahashi H, Nawa H. 1996. Regional specificity of alterations in NGF BDNF and NT-3 levels in Alzheimer's disease. Neuroreport 7:2925-2928.
93. Niewiadomska G, Baksalerska-Pazera M, Lenarcik I, Riedel G. 2006a. Compartmental protein expression of Tau. GSK-3b and Trk A in cholinergic neurons of aged rats J Neural Transm 113:1733-1746.
94. Niewiadomska G, Baksalerska-Pazera M, Riedel G. 2005. Altered cellular distribution of phospho-tau proteins coincides with impaired retrograde axonal transport in neurons of aged rats. Ann NY Acad Sci 1048:287-295.
95. Niewiadomska G, Baksalerska-Pazera M, Riedel G. 2006b. Cytoskeletal transport in the aging brain: Focus on the cholinergic system. Rev Neurosci 17:581-618. Review.
96. Nuydens R, Dispersyn G, de Jong M, van den Kieboom G, Borgers M, Geerts H. 1997. Aberrant tau phosphorylation and neurite retraction during NGF deprivation in PC12 cells. Biochem Biophys Res Commun 26;240:687-691.
97. Nykjaer A, Lee R, Teng KK, Jansen P, Madsen P, Nielsen MS, Jacobsen C, et al. 2004. Sortilin is essential for proNGF-induced neuronal cell death. Nature 26;427:843-848.
98. Olivieri G, Otten U, Meier F, Baysang G, Dimitriades-Schmutz B, Müller-Spahn F, Savaskan E. 2002. Oxidative stress modulates tyrosine kinase receptor A and p75 receptor (low-affinity nerve growth factor receptor) expression in SHSY5Y neuroblastoma cells. Neurol Clin Neurophysiol. 2002:2-10.
99. Origlia N, Capsoni S, Domenici L, Cattaneo A. 2006. Time window in cholinomimetic ability to rescue long-term potentiation in neurodegenerating anti-nerve growth factor mice. J Alzheimers Dis 9:59-68.
100. Peng S, Wuu J, Mufson EJ, Fahnestock M. 2004. Increased proNGF levels in subjects with mild cognitive impairment and mild Alzheimer disease. J Neuropathol Exp Neurol 63:641-649.
101. Pesavento E, Capsoni S, Domenici L, Cattaneo A. 2002. Acute cholinergic rescue of synaptic plasticity in the neurodegenerating cortex of anti-nerve-growth-factor mice. Eur J Neurosci 15:1030-1036.
102. Pesavento E, Margotti E, Righi M, Cattaneo A, Domenici L. 2000. Blocking the NGF-TrkA interaction rescues the developmental loss of LTP in the rat visual cortex: Role of the cholinergic system. Neuron 25:165-175.
103. Pizzorusso T, Berardi N, Rossi FM, Viegi A, Venstrom K, Reichardt LF, Maffei L. 1999. TrkA activation in the rat visual cortex by antirat trkA IgG prevents the effect of monocular deprivation. Eur J Neurosci 1:204-212.
104. Plo I, Bono F, Bezombes C, Alam A, Bruno A, Laurent G. 2004. Nerve growth factor-induced protein kinase C stimulation contributes to TrkA-dependent inhibition of p75 neurotrophin receptor sphingolipid signaling. J Neurosci Res 77:465-474.
105. Pomponi M, Bria P, Pomponi M. 2008. Is Alzheimer's disease a synaptic disorder? J Alzheimers Dis 13:39-47. Review.
106. Poo MM. 2001. Neurotrophins as synaptic modulators. Nat Rev Neurosci 2:24-32.
107. Poon WW, Blurton-Jones M, Tu CH, Feinberg LM, Chabrier MA, Harris JW, Jeon NL, et al. Beta-Amyloid impairs axonal BDNF retrograde trafficking. Neurobiol Aging. http://dx.doi.org/10.1016/j.neurobiolaging.2009.05.012. DOI:10.1016/j.neurobiolaging.2009.05.012.
108. Puglielli L, Ellis BC, Saunders AJ, Kovacs DM. 2003. Ceramide stabilizes β-site amyloid precursor protein-cleaving enzyme 1 and promotes amyloid β-peptide biogenesis. J Biol Chem 278:19777-19783.
109. Rossner S, Ueberham U, Schliebs R, Perez-Polo JR, Bigl V. 1998. p75 and TrkA receptor signaling independently regulate amyloid precursor protein mRNA expression, isoform composition, and protein secretion in PC12 cells. J Neurochem 71:757-766.
110. Ruberti F, Capsoni S, Comparini A, Di Daniel E, Franzot J, Gonfloni S, Rossi G, et al. 2000. Phenotypic knockout of nerve growth factor in adult transgenic mice reveals severe deficits in basal forebrain cholinergic neurons, cell death in the spleen, and skeletal muscle dystrophy. J Neurosci 20:2589-2601.
111. Rudy B, Kirschenbaum B, Rukenstein A, Greene LA. 1987. Nerve growth factor increases the number of functional Na channels and induces TTX-resistant Na channels in PC12 pheochromocytoma cells. J Neurosci 7:1613-1625.
112. Sadot E, Heicklen-Klein A, Barg J, Lazarovici P, Ginzburg I. 1996. Identification of a tau promoter region mediating tissue-specific-regulated expression in PC12 cells. J Mol Biol 258:539.
113. Salehi A, Delcroix JD, Swaab DF. 2004. Alzheimer's disease and NGF signaling. J Neural Transm 111:323-345.
114. Salehi A, Ocampo M, Verhaagen J, Swaab DF. 2000. P75 neurotrophin receptor in the nucleus basalis of meynert in relation to age, sex, and Alzheimer's disease. Exp Neurol 161:245-258.
115. Salehi A, Verhaagen J, Dijkhuizen PA, Swaab DF. 1996. Colocalization of high-affinity neurotrophin receptors in nucleus basalis of Meynert neurons and their differential reduction in Alzheimer's disease. Neuroscience 75:373-387.
116. Sandow SL, Heydon K, Weible MW II, Reynolds AJ, Bartlett SE, Hendry IA. 2000. Signaling organelle for retrograde axonal transport of internalized neurotrophins from the nerve terminal. Immunol Cell Biol 78:430-435.
117. Savaskan E, Müller-Spahn F, Olivieri G, Bruttel S, Otten U, Rosenberg C, Hulette C, et al. 2000. Alterations in trk A, trk B and trk C receptor immunoreactivities in parietal cortex and cerebellum in Alzheimer's disease. Eur Neurol 44:172-180.
118. Scharfman H, Goodman J, Macleod A, Phani S, Antonelli C, Croll S. 2005. Increased neurogenesis and the ectopic granule cells after intrahippocampal BDNF infusion in adult rats. Exp Neurol 192:348-356.
119. Schindowski K, Belarbi K, Buée L. 2008. Neurotrophic factors in Alzheimer's disease: Role of axonal transport. Genes Brain Behav 1:43-56. Review.
120. Schulte-Herbrüggen O, Hamker U, Meske V, Danker-Hopfe H, Ohm TG, Hellweg R. 2007. β/A4-Amyloid increases nerve growth factor production in rat primary hippocampal astrocyte cultures. Int J Dev Neurosci 25:387-390.
121. Schuman EM. 1999. Neurotrophin regulation of synaptic transmission. Curr Opin Neurobiol 9:105-109. Review.
122. Scott SA, Mufson EJ, Weingartner JA, Skau KA, Crutcher KA. 1995. Nerve growth factor in Alzheimer's disease: Increased levels throughout the brain coupled with declines in nucleus basalis. J Neurosci 15:6213-6221.
123. Shelton SB, Johnson GV. 2001. Tau and HMW tau phosphorylation and compartmentalization in apoptotic neuronal PC12 cells. J Neurosci Res 66:203-213.
124. Sola E, Capsoni S, Rosato-Siri M, Cattaneo A, Cherubini E. 2006. Failure of nicotine-dependent enhancement of synaptic efficacy at Schaffer-collateral CA1 synapses of AD11 anti-nerve growth factor transgenic mice. Eur J Neurosci 24:1252-1264.
125. Sotthibundhu A, Sykes AM, Fox B, Underwood CK, Thangnipon W, Coulson EJ. 2008. b-amyloid(1-42) induces neuronal death through the p75 neurotrophin receptor. J Neurosci 9;28:3941-3946.
126. Stamer K, Vogel R, Thies E, Mandelkow E, Mandelkow EM. 2002. Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J Cell Biol 18;156:1051-1063.
127. Stokin GB, Goldstein LS. 2006 Axonal transport and Alzheimer's disease. Annu Rev Biochem 75:607-627. Review.
128. Stokin GB, Lillo C, Falzone TL, Brusch RG, Rockenstein E, Mount SL, Raman R, et al. 2005. Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 307:1282-1288.
129. Stoothoff WH, Johnson GV. 2005. Tau phosphorylation: Physiological and pathological consequences. Biochim Biophys Acta 1739(2-3):280-297. Review.
130. Susen K, Blöchl A. 2005. Low concentrations of aggregated β-amyloid induce neurite formation via the neurotrophin receptor p75. J Mol Med 83:720-735.
131. Svendsen CN, Cooper JD, Sofroniew MV. 1991. Trophic factor effects on septal cholinergic neurons. Ann NY Acad Sci 640:91-94.
132. Tancredi V, D'Arcangelo G, Mercanti D, Calissano P. 1993. Nerve growth factor inhibits the expression of long-term potentiation in hippocampal slices. Neuroreport 4:147-150.
133. Tatebayashi Y, Haque N, Tung YC, Iqbal K, Grundke-Iqbal I. 2004. Role of tau phosphorylation by glycogen synthase kinase-3b in the regulation of organelle transport. J Cell Sci 117(Part 9):1653-1663.
134. Thies E, Mandelkow EM. 2007. Missorting of tau in neurons causes degeneration of synapses that can be rescued by the kinase MARK2/Par-1. J Neurosci 27:2896-2907.
135. Thoenen H. 1995. Neurotrophins and neuronal plasticity. Science 270:593-598.
136. Toledo-Aral JJ, Brehm P, Halegoua S, Mandel G. 1995. A single pulse of nerve growth factor triggers long-term neuronal excitability through sodium channel gene induction. Neuron 14:607-611.
137. Tuszynski MH, Thal L, Pay M, Salmon DP, U HS, Bakay R, Patel P, et al. 2005. A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat Med 11:551-555.
138. Urra MS, Escudero CA, Ramos P, Lisbona MF, Allende E, Covarrubias P, Parraguez JI, et al. 2007. TrkA receptor activation by NGF induces shedding of the p75 neurotrophin receptor followed by endosomal γ-secretase-mediated release of the p75 intracellular domain. J Biol Chem 282:7606-7615.
139. Venero JL, Knüsel B, Beck KD, Hefti F. 1994. Expression of neurotrophin and trk receptor genes in adult rats with fimbria transections: Effect of intraventricular nerve growth factor and brain-derived neurotrophic factor administration. Neuroscience 59:797-815.
140. Villa A, Latasa MJ, Pascual A. 2001. Nerve growth factor modulates the expression and secretion of b-amyloid precursor protein through different mechanisms in PC12 cells. J Neurochem 77:1077-1084.
141. Watson FL, Heerssen HM, Moheban DB, Lin MZ, Sauvageot CM, Bhattacharyya A, Pomeroy SL, et al. 1999. Rapid nuclear responses to target-derived neurotrophins require retrograde transport of ligand-receptor complex. J Neurosci 15;19:7889-7900.
142. Williams BJ, Eriksdotter-Jonhagen M, Granholm AC. 2006. Nerve growth factor in treatment and pathogenesis of Alzheimer's disease. Prog Neurobiol 80:114-128.
143. Wu C, Ramirez A, Cui B, Ding J, Delcroix JD, Valletta JS, Liu JJ, et al. 2007. A functional dynein-microtubule network is required for NGF signaling through the Rap1/MAPK pathway. Traffic 8:1503-1520.
144. Yaar M, Zhai S, Fine R, Eisenhauer PB, Arble B, Stewart KB, Gilchrest BA. 2002. Amyloid β binds trimers as well as monomers of the 75-kDa neurotrophin receptor and activates receptor signaling. J Biol Chem 277:7720-7725.
145. Yang T, Knowles JK, Lu Q, Zhang H, Arancio O, Moore LA, Chang T, et al. 2008. Small molecule, non-peptide p75 ligands inhibit Abeta-induced neurodegeneration and synaptic impairment. PLoS One 3:e3604.
146. Yano H, Lee FS, Kong H, Chuang J, Arevalo J, Perez P, Sung C, et al. 2001. Association of Trk neurotrophin receptors with components of the cytoplasmic dynein motor. J Neurosci 21:RC125.